| Application no. and date | 09730852.2 (espacenet) (Federated) (European Patent Register), 20090410 | | Patent/reg. no. and date | DK/EP 2281037, 20151111 | | Publication date | 20110209 | | Priority no. and date | US 124021 P, 20080411 | | EP pub. no. and date |
EP 2281037 20110209 | | Effective date | | | Applicant/owner | Catalyst Biosciences, Inc., 260 Littlefield Avenue
South San Francisco, CA 94080, US | | Applicant ref. no. | 6.1510.026 | | Inventor | MADISON, Edwin, L., 558 48th Avenue
San Francisco, CA 94121, US,
THANOS, Christopher, 3579 Sacramento Street
San Francisco, CA 94118, US | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | C12N 9/64 (2006.01) | | Title | Faktor VII-polypeptider som er modificerede og anvendelser deraf | | Int. application no. | US2009002248 | | Int. publication no. | WO2009126307 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
